Latest Morning Briefing Stories

Americans Eager For Leaders To Cooperate To Make Health Law Work

KFF Health News Original

Majorities of Democrats and Republicans — and people who say they are supporters of President Donald Trump — say they want the country to make the law successful.

Podcast: ‘What The Health?’ No Vacation For Insurers

KFF Health News Original

In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Sarah Kliff of Vox.com, and Margot Sanger-Katz of The New York Times discuss the state of the individual health insurance markets in the wake of the failure (for now) of Congress’s efforts to repeal and replace the Affordable Care Act.

Senate Democrats Delay HHS Nominee Over Women’s Health Funding

KFF Health News Original

Sen. Patty Murray questions Dr. Brett Giroir’s willingness to stand up for women’s health programs such as family planning services and teenage pregnancy prevention.

Medi-Cal Sued For Pushing Patients Into Managed Care Despite Judges’ Orders

KFF Health News Original

Advocates say California’s Medicaid program is violating its own rules by overturning decisions that would allow seriously ill patients to stay out of managed care and keep their doctors.

Lag In Brain Donation Hampers Understanding Of Dementia In Blacks

KFF Health News Original

A long history of racism and cruel experimentation in health care are among the reasons African-American families oppose donating patients’ brains for study.

Taking A U-Turn On Benefits, Big Employers Vow To Continue Offering Health Insurance

KFF Health News Original

Three years ago, only about a quarter of the nation’s large employers were very confident they would have a health plan in 10 years. That number has now risen to 65 percent.

Health Gap Widens Between Appalachia And Rest Of The U.S.

KFF Health News Original

In the early 1990s, people in this economically depressed region lagged only slightly behind other parts of the country. Today, rates of infant mortality in Appalachia are significantly higher than elsewhere, and the difference in life expectancy has grown noticeably.

Why One Insurer’s Collapse Could Whack Insurers, Policyholders Across the Country

KFF Health News Original

Little-known rules require all health insurance companies to help pay claims when any one of them fails. Penn Treaty failed big — and insurers around the country are likely to pass those costs onto policyholders.

‘Bureaucratic Ninjas’ Slice Red-Tape To Battle Health Disparities

KFF Health News Original

A person’s ZIP code can be as important to her health as her genetic code. One large health system has begun to tackle the social challenges that influence a person’s health by asking questions and giving extra help to people in need.

Despite Insurers’ Tactical Win On ACA’s Cost-Sharing Payments, Uncertainty Lingers

KFF Health News Original

Court allows state attorneys general to join a pending legal challenge to keep billions in subsidies flowing to consumers and insurers, despite the Trump administration’s resistance.

Anthem’s Retreat Leaves Californians With Fewer Choices, More Worries

KFF Health News Original

The nation’s second-largest insurer is shrinking its presence on Obamacare exchanges and in the broader individual market in response to prevailing uncertainty. California is just the latest — and the biggest — example.

Covered California Expects 12.5% Average Rate Rise In 2018

KFF Health News Original

The figure could be higher if President Trump ends an important consumer subsidy, which he has threatened to do. The exchange also announced that Anthem Blue Cross will pull out of Covered California and the overall individual market in 16 of the 19 regions it currently serves.

Denial, Appeal, Approval … An Adult’s Thorny Path To Spinraza Coverage

KFF Health News Original

The FDA granted approval for Spinraza in late December for use on children and adults with spinal muscular atrophy. Insurance coverage is mostly focused on infants and children.

Drug Puts A $750,000 ‘Price Tag On Life’

KFF Health News Original

The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.